Eyeing The Future: AstraZeneca Farms Out Compounds To Ocular Specialist Alcon
Alcon's now-tenuous relationship with Novartis is unlikely to affect the new five-year research agreement with AstraZeneca.
Alcon's now-tenuous relationship with Novartis is unlikely to affect the new five-year research agreement with AstraZeneca.